abrdn plc boosted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,135,267 shares of the real estate investment trust’s stock after purchasing an additional 15,805 shares during the quarter. abrdn plc owned about 0.42% of Omega Healthcare Investors worth $43,055,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Geode Capital Management LLC lifted its stake in Omega Healthcare Investors by 3.1% in the 3rd quarter. Geode Capital Management LLC now owns 6,426,129 shares of the real estate investment trust’s stock worth $261,589,000 after purchasing an additional 192,465 shares in the last quarter. State Street Corp lifted its stake in Omega Healthcare Investors by 0.9% in the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock worth $502,228,000 after purchasing an additional 114,085 shares in the last quarter. Assetmark Inc. lifted its stake in Omega Healthcare Investors by 1.7% in the 3rd quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock worth $48,492,000 after purchasing an additional 19,542 shares in the last quarter. Post Resch Tallon Group Inc. purchased a new stake in Omega Healthcare Investors in the 4th quarter worth $1,250,000. Finally, BNP Paribas Financial Markets lifted its stake in Omega Healthcare Investors by 120.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust’s stock worth $9,212,000 after purchasing an additional 123,836 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.
Omega Healthcare Investors Price Performance
Shares of OHI stock opened at $38.33 on Thursday. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The company has a market capitalization of $10.35 billion, a P/E ratio of 28.18, a P/E/G ratio of 1.08 and a beta of 0.99. The company’s 50-day simple moving average is $38.16 and its two-hundred day simple moving average is $39.08. Omega Healthcare Investors, Inc. has a one year low of $27.74 and a one year high of $44.42.
Omega Healthcare Investors Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th will be paid a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, February 10th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.99%. Omega Healthcare Investors’s dividend payout ratio is presently 197.06%.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on the stock. Mizuho upped their target price on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a research report on Thursday, December 5th. Royal Bank of Canada upped their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price on the stock in a research report on Monday, December 9th. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 target price on the stock. Finally, BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Omega Healthcare Investors presently has an average rating of “Moderate Buy” and an average target price of $41.67.
Check Out Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
See Also
- Five stocks we like better than Omega Healthcare Investors
- What does consumer price index measure?
- 3 Must-Have ETFs Set to Dominate This Quarter
- Manufacturing Stocks Investing
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Insider Buying Explained: What Investors Need to Know
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.